Group One Trading
ARLZ

Group One Trading’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Group One Trading’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-19,400
Closed -$29K – 5858
2018
Q1 		$29K Buy
19,400
+13,400
+223% +$23.4K ﹤0.01% 3938
2017
Q4 		$9K Sell
6,000
-59,000
-91% -$96.8K ﹤0.01% 4432
2017
Q3 		$149K Buy
65,000
+50,700
+355% +$67.9K ﹤0.01% 2975
2017
Q2 		$19K Sell
14,300
-84,900
-86% -$123K ﹤0.01% 3986
2017
Q1 		$212K Buy
99,200
+90,900
+1,095% +$342K ﹤0.01% 2484
2016
Q4 		$37K Sell
8,300
-126,600
-94% -$601K ﹤0.01% 3436
2016
Q3 		$654K Buy
134,900
+4,900
+4% +$22.3K 0.01% 1610
2016
Q2 		$429K Buy
130,000
+105,800
+437% +$399K 0.01% 1850
2016
Q1 		$86K Buy
+24,200
New +$125K ﹤0.01% 2936

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Group One Trading's ARLZ Position: Q3 2018 in Review

Group One Trading sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 45,671 shares — an estimated $16K sold.

Group One Trading first reported a position in ARLZ in Q1 2016 and held it in 9 quarters. The position peaked at $480K in Q4 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Group One Trading reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Group One Trading sold 45,671 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $16K.
  • Group One Trading first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 9 quarters.
  • Group One Trading's Aralez Pharmaceuticals Inc. position peaked at $480K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Group One Trading's 13F filing for Q3 2018, filed 8 Nov 2018.